Insuficiencia cardiaca avanzada e transplante cardiaco: Envíos recentes
Mostrando ítems 1-5 de 164
-
Sex differences in heart failure with reduced ejection fraction in the GALACTIC-HF trial
(Elsevier on behalf of the American College of Cardiology Foundation, 2023-10-11)[Abstract] Background: Women with heart failure with reduced ejection fraction (HFrEF) receive less guideline-recommended therapy and experience worse quality of life than men. Objectives: The authors sought to assess ... -
Assessing the relationship between molecular rejection and parenchymal injury in heart transplant biopsies
(Wolters Kluwer, 2022-11)[Abstract] Background: The INTERHEART study (ClinicalTrials.gov #NCT02670408) used genome-wide microarrays to detect rejection in endomyocardial biopsies; however, many heart transplants with no rejection have late dysfunction ... -
The consequences of the COVID‐19 pandemic for self‐care in patients supported with a left ventricular assist device
(European Society of Cardiology, 2020-06) -
International Consortium for Health Outcomes Measurement (ICHOM): standardized patient-centered outcomes measurement set for heart failure patients
(American College of Cardiology Foundation, 2020-03)[Abstract] Whereas multiple national, international, and trial registries for heart failure have been created, international standards for clinical assessment and outcome measurement do not currently exist. The working ... -
Risks of ventricular arrhythmia and heart failure in carriers of RBM20 variants
(American Heart Association, 2023-10)[Abstract] Background: Variants in RBM20 are reported in 2% to 6% of familial cases of dilated cardiomyopathy and may be associated with fatal ventricular arrhythmia and rapid heart failure progression. We sought to determine ...